Managing Cystic Fibrosis
- 1 June 2011
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 183 (11), 1463-1471
- https://doi.org/10.1164/rccm.201009-1478ci
Abstract
The survival of patients with cystic fibrosis (CF) continues to improve. The discovery and cloning of the CFTR gene more than 21 years ago led to the identification of the structure and function of the CFTR chloride channel. New therapies based on the understanding of the function of CFTR are currently under development. The better clinical status and improved survival of patients with CF is not only a result of understanding of the molecular mechanisms of CF but also a result of the development of therapeutic strategies that are based on insights into the natural course of the disease. Current CF treatments that target respiratory infections, inflammation, mucociliary clearance, and nutritional status are associated with improved pulmonary function and reduced exacerbations. Patients benefit from treatment at a specialized CF center by a multidisciplinary dedicated team with emphasis being placed on frequent visits, periodic testing, and monitoring adherence to therapy. The purpose of this review is to survey recent developments in CF care that are responsible for the improved survival and quality of life of patients with CF.Keywords
This publication has 102 references indexed in Scilit:
- Cell phone intervention to improve adherence: Cystic fibrosis care team, patient, and parent perspectivesPediatric Pulmonology, 2010
- Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal InfectionAntimicrobial Agents and Chemotherapy, 2009
- Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due toPseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- High-Dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness TrialThe Journal of Pediatrics, 2007
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Diabetes mellitus associated with cystic fibrosisThe Journal of Pediatrics, 1988
- Complications of gastroesophageal reflux in patients with cystic fibrosisThe Journal of Pediatrics, 1982